<DOC>
	<DOCNO>NCT00149136</DOCNO>
	<brief_summary>ALL patient age 55 year older treat steroid one week Ph+ve case offer specific therapy include induction treatment steroid , cyclophosphamide , daunorubicin vincristine , follow , irrespective response induction chemotherapy , imatinib , 600 mg daily , combine intermittent steroid 2 month . Patients complete response ( CR ) give 10 block alternate chemotherapy , include 2 additional two-month block imatinib , total treatment duration 2 year . Therapy occult central nervous system leukemia include 5 intrathecal injection methotrexate cranial irradiation . Duration therapy : 2 year .</brief_summary>
	<brief_title>Treatment Philadelphia-Positive Acute Lymphocytic Leukemia ( Ph+ ALL ) Elderly With Imatinib Mesylate ( STI571 ) Chemotherapy .</brief_title>
	<detailed_description />
	<mesh_term>Leukemia</mesh_term>
	<mesh_term>Leukemia , Lymphoid</mesh_term>
	<mesh_term>Precursor Cell Lymphoblastic Leukemia-Lymphoma</mesh_term>
	<mesh_term>Imatinib Mesylate</mesh_term>
	<criteria>Ph+ ALL patient 55 year old Signed write informed consent CML transformation Concomitant malignancy Previous treatment Imatinib Severe organ condition</criteria>
	<gender>All</gender>
	<minimum_age>55 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>April 2007</verification_date>
	<keyword>Acute Lymphocytic Leukemia ,</keyword>
	<keyword>Ph+ ,</keyword>
	<keyword>elderly patient ,</keyword>
	<keyword>Imatinib</keyword>
</DOC>